Ultrasonic Catheter
The SonoGuide is our technology breakthrough device for recurrent fatal brain cancer.
The SonoGuide, which was developed by our subsidiary Sonenco Ltd., is practically the only viable solution that can deliver chemotherapy to brain tumors.
The SonoGuide leading tip ultrasonic vibrations disperse heavy nano-particles carrying chemotherapy agents. The ultrasonic vibration “shoots” the nano-particles into the malignant tissue area.
The Sonoguide is administered to the brain tumor via a standard stereotactic procedure, which only takes a few minutes.
Sonenco has completed animal studies that show an outstanding dispersion performance, with no damage to the healthy brain tissue and the animal subject.
Competitive Advantage
SonoGuide’s superior solution offers the following advantages:
Minimal invasive short procedure (a few minutes).
Ability to administer large volumes of drug dispersion.
Continuous target site drug exposure..
Energy for maximum efficient dispersion is well below medical energy level restrictions.
Precise dispersion profile to meet medical demands derived from fine-tuning and adjustment flexibility by effective use of all eadjustable parameters.
andn
Disclaimer: I post on stocks that I own or am thinking about owning. Do your DD, buy and sell based on that DD.
News 
Market Data 
Discover 
